Guillaume Cadiot

14.3k total citations · 2 hit papers
213 papers, 8.7k citations indexed

About

Guillaume Cadiot is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Guillaume Cadiot has authored 213 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 158 papers in Epidemiology, 114 papers in Oncology and 78 papers in Neurology. Recurrent topics in Guillaume Cadiot's work include Neuroendocrine Tumor Research Advances (138 papers), Neuroblastoma Research and Treatments (76 papers) and Lung Cancer Research Studies (72 papers). Guillaume Cadiot is often cited by papers focused on Neuroendocrine Tumor Research Advances (138 papers), Neuroblastoma Research and Treatments (76 papers) and Lung Cancer Research Studies (72 papers). Guillaume Cadiot collaborates with scholars based in France, United States and Germany. Guillaume Cadiot's co-authors include Philippe Ruszniewski, M Mignon, Guido Rindi, Jarosław B. Ćwikła, Eva Sedláčková, Lucy Wall, Marianne Pavel, Alexandria T. Phan, Martyn Caplin and Edward M. Wolin and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Guillaume Cadiot

201 papers receiving 8.5k citations

Hit Papers

Lanreotide in Metastatic Enteropancreatic Neuroendocrine ... 2009 2026 2014 2020 2014 2009 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
    2014 1.3k citations Martyn Caplin, Marianne Pavel et al. New England Journal of Medicine profile →
  2. Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial
    2009 487 citations James C. Yao, Catherine Lombard‐Bohas et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guillaume Cadiot France 51 6.7k 5.1k 4.0k 1.6k 1.2k 213 8.7k
Francesco Tonelli Italy 33 2.1k 0.3× 1.5k 0.3× 752 0.2× 1.5k 1.0× 1.5k 1.2× 141 5.3k
Sara Massironi Italy 35 2.4k 0.4× 1.3k 0.3× 657 0.2× 1.2k 0.8× 576 0.5× 150 4.1k
Virginie Verkarre France 41 3.4k 0.5× 1.5k 0.3× 330 0.1× 2.0k 1.3× 718 0.6× 141 8.5k
Aurelio Sonzogni Italy 30 1.9k 0.3× 528 0.1× 593 0.1× 1.2k 0.8× 214 0.2× 102 5.0k
Beat Gloor Switzerland 38 1.1k 0.2× 2.7k 0.5× 455 0.1× 3.0k 1.9× 170 0.1× 155 5.1k
Archie H. Baggenstoss United States 42 3.2k 0.5× 1.0k 0.2× 397 0.1× 1.7k 1.1× 363 0.3× 125 6.0k
Alan K. Foulis United Kingdom 42 837 0.1× 2.6k 0.5× 243 0.1× 3.1k 1.9× 2.5k 2.0× 82 6.9k
P. Pederzoli Italy 32 1.6k 0.2× 3.5k 0.7× 476 0.1× 2.9k 1.8× 79 0.1× 90 4.5k
James C. Andrews United States 41 1.4k 0.2× 887 0.2× 407 0.1× 2.9k 1.8× 361 0.3× 133 6.0k
Jérôme Dumortier France 40 2.9k 0.4× 862 0.2× 147 0.0× 2.4k 1.5× 100 0.1× 284 6.4k

Countries citing papers authored by Guillaume Cadiot

Since Specialization
Citations

This map shows the geographic impact of Guillaume Cadiot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guillaume Cadiot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guillaume Cadiot more than expected).

Fields of papers citing papers by Guillaume Cadiot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guillaume Cadiot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guillaume Cadiot. The network helps show where Guillaume Cadiot may publish in the future.

Co-authorship network of co-authors of Guillaume Cadiot

This figure shows the co-authorship network connecting the top 25 collaborators of Guillaume Cadiot. A scholar is included among the top collaborators of Guillaume Cadiot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guillaume Cadiot. Guillaume Cadiot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Peyrin‐Biroulet, Laurent, et al.. (2024). Long-Term Neoplastic Risk Associated With Colorectal Strictures in Crohn’s Disease: A Multicenter Study. SHILAP Revista de lepidopterología. 3(6). 731–737. 1 indexed citations
3.
Poncet, Gilles, et al.. (2022). Concept of reintervention with thorough lymphadenectomy after suboptimal resection of small‐intestine neuroendocrine neoplasms: A multicentre preliminary study. Journal of Neuroendocrinology. 34(6). e13117–e13117. 3 indexed citations
4.
Perrier, Marine, Olivia Hentic, Hédia Brixi, et al.. (2022). FOLFOX ‐bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors. Journal of Neuroendocrinology. 35(1). e13227–e13227. 8 indexed citations
5.
Delemer, Brigitte, Romain Coriat, Denis Smith, et al.. (2020). Evaluation of Nurses’ and Patients’ Overall Satisfaction with New and Previous Formulations of Octreotide Long-acting Release (Sandostatin LAR®): A French Observational Study. Advances in Therapy. 37(9). 3901–3915. 1 indexed citations
6.
Mestier, Louis de, Jérôme Cros, Olivia Hentic, et al.. (2019). Lesion-by-lesion correlation between uptake at FDG PET and the Ki67 proliferation index in resected pancreatic neuroendocrine tumors. Digestive and Liver Disease. 51(12). 1720–1724. 16 indexed citations
7.
Roquin, Guillaume, Éric Terrebonne, Thierry Lecomte, et al.. (2019). Endoscopic management of 345 small rectal neuroendocrine tumours: A national study from the French group of endocrine tumours (GTE). United European Gastroenterology Journal. 7(8). 1102–1112. 44 indexed citations
8.
Dignaß, Axel, Ayesha Akbar, Daniel C. Baumgart, et al.. (2018). Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis. Scandinavian Journal of Gastroenterology. 53(4). 442–448. 13 indexed citations
9.
10.
11.
Lardière-Deguelte, Sophie, Louis de Mestier, F. Appere, et al.. (2015). Toward a Preoperative Classification of Lymph Node Metastases in Patients with Small Intestinal Neuroendocrine Tumors in the Era of Intestinal-Sparing Surgery. Neuroendocrinology. 103(5). 552–559. 57 indexed citations
12.
Caplin, Martyn, Marianne Pavel, Jarosław B. Ćwikła, et al.. (2014). Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors. New England Journal of Medicine. 371(3). 224–233. 1286 indexed citations breakdown →
13.
Yao, James C., Catherine Lombard‐Bohas, Éric Baudin, et al.. (2009). Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial. Journal of Clinical Oncology. 28(1). 69–76. 487 indexed citations breakdown →
14.
Heurgué, Alexandra, Fabien Vitry, Marie-Danièle Diébold, et al.. (2007). Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease. Gastroentérologie Clinique et Biologique. 31(1). 17–25. 55 indexed citations
15.
Calender, Alain, Guillaume Cadiot, & M Mignon. (2001). Néoplasie endocrinienne multiple de type 1 : aspects génétiques et cliniques. Gastroentérologie Clinique et Biologique. 25(4). 3 indexed citations
16.
Cadiot, Guillaume, D Rigaud, T. Coste, et al.. (1997). Multivariate analysis of pathophysiological factors in reflux oesophagitis.. Gut. 40(2). 167–174. 86 indexed citations
17.
18.
19.
Lehy, Thérèse, Guillaume Cadiot, M Mignon, P. Ruszniewski, & S Bonfils. (1992). Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome.. Gut. 33(9). 1275–1279. 113 indexed citations
20.
Cadiot, Guillaume, et al.. (1990). Maladie coeliaque et colite collagène. Une association fortuite. La Presse Médicale. 19(35). 1621–1622. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Tonelli Breakdown of academic impact, for papers by Sara Massironi Breakdown of academic impact, for papers by Virginie Verkarre Breakdown of academic impact, for papers by Aurelio Sonzogni Breakdown of academic impact, for papers by Beat Gloor Breakdown of academic impact, for papers by Archie H. Baggenstoss Breakdown of academic impact, for papers by Alan K. Foulis Breakdown of academic impact, for papers by P. Pederzoli Breakdown of academic impact, for papers by James C. Andrews Breakdown of academic impact, for papers by Jérôme Dumortier
Rankless by CCL
2026